Advertisement
Marrone Bio Innovations, Inc.

Marrone Bio Innovations, Inc. (MBII) Stock Competitors & Peer Comparison

See (MBII) competitors and their performances in Stock Market.

MBIINASDAQ
Basic MaterialsAgricultural Inputs
$0.80
$0.20(20.19%)
U.S. Market is Open · 14:01
Advertisement

Peer Comparison Table: Agricultural Inputs Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MBII$0.80-20.19%0-6.82-$0.12N/A
CTA-PB$67.30+0.15%58.6BN/AN/A+0.97%
CTVA$75.71-0.20%50.2B40.55$1.85+0.97%
CTA-PA$53.10-1.02%35.9BN/AN/A+0.97%
NTR$65.50-2.65%31.9B13.51$4.91+3.30%
CF$109.46+0.01%16.7B9.78$11.10+1.86%
ICL$5.54-0.98%7.2B26.62$0.21+3.43%
MOS$20.58-3.77%6.8B152.00$0.14+4.13%
SMG$59.45+3.34%3.5B17.13$3.48+4.43%
FMC$11.36+2.30%1.4B-0.59-$19.62+11.39%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MBII vs CTA-PB Comparison June 2026

MBII plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MBII stands at 0. In comparison, CTA-PB has a market cap of 58.6B. Regarding current trading prices, MBII is priced at $0.80, while CTA-PB trades at $67.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MBII currently has a P/E ratio of -6.82, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, MBII's ROE is -0.54%, compared to CTA-PB's ROE of +0.05%. Regarding short-term risk, MBII is more volatile compared to CTA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for MBII.Check CTA-PB's competition here

Stock price comparison of stocks in the Basic Materials Sector

Loading...

Frequently Asked Questions